Atwater Malick LLC Novo Nordisk A S Transaction History
Atwater Malick LLC
- $293 Million
- Q1 2025
A detailed history of Atwater Malick LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Atwater Malick LLC holds 163,869 shares of NVO stock, worth $11.2 Million. This represents 3.88% of its overall portfolio holdings.
Number of Shares
163,869
Previous 162,228
1.01%
Holding current value
$11.2 Million
Previous $14 Million
18.45%
% of portfolio
3.88%
Previous 4.69%
Shares
26 transactions
Others Institutions Holding NVO
# of Institutions
1,768Shares Held
330MCall Options Held
11.3MPut Options Held
15.5M-
Jennison Associates LLC18.8MShares$1.29 Billion0.93% of portfolio
-
Bank Of America Corp Charlotte, NC14.8MShares$1.01 Billion0.08% of portfolio
-
Loomis Sayles & CO L P12.4MShares$849 Million1.24% of portfolio
-
Morgan Stanley New York, NY12.3MShares$844 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa11.9MShares$813 Million0.36% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $155B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...